Five Budgets Walked Into Our Clinic: The Diagnoses and Prescriptions That Changed Everything

Every budget that walks through our door tells a story. Some arrive wheezing. Some look healthy but have underlying conditions. And some just need a second opinion before the finance director signs something they'll regret in Q3.

We've pulled five anonymised budgets from our case files — all real UK businesses, all names changed, all outcomes measured. Read them like a doctor's notes. One of them is probably you.

Patient One: The Coffee Chain With a Boosted Post Habit

Presenting symptoms. An independent coffee chain, four sites across the North West, spending £1,200 a month almost entirely on boosting organic posts. Reach looked lovely. Sales didn't move.

Diagnosis. Classic vanity metric addiction. The boosted posts were reaching people 200 miles away who would never buy a flat white. Meanwhile, the actual local audience — the people who could walk to a branch — were seeing generic brand content instead of offers, events, and reasons to come in this week.

Prescription. Redirect 70% of spend into tightly geo-targeted campaigns within three miles of each site, promoting a single clear offer. Keep 30% for boosting only the posts that already perform organically. Introduce a simple till code per campaign so results are tracked in revenue, not impressions.

Prognosis. Within eight weeks, cost per store visit dropped by over half, and weekend footfall at the weakest site rose measurably. Reach fell. Revenue didn't.

Patient Two: The B2B Software Firm That Paid for Ads Before It Had Anything to Advertise

Presenting symptoms. A SaaS company putting £5,000 a month into LinkedIn ads with a content library consisting of three blog posts from 2022 and a logo.

Diagnosis. Cart before horse, paid before organic. Ads amplify what exists — and what existed wasn't worth amplifying. Prospects clicked through, found nothing substantial, and bounced.

Prescription. A three-month ad pause. Reinvest into a lean organic engine: two genuinely useful articles a month, a monthly customer story, and founder-led posts on LinkedIn. Ads resume only once landing pages and proof points exist.

Prognosis. When paid resumed in month four, cost per qualified lead dropped by roughly 40% versus the old baseline. Same budget, healthier patient.

Patient Three: The Fashion Retailer Starving Its Own Content

Presenting symptoms. A mid-size online retailer splitting budget 80/20 between paid media and content production — and the 20% covered a photographer for one shoot a year.

Diagnosis. Content anaemia. By March, the same campaign imagery had been running for a quarter. Fatigue set in, frequency climbed, click-through rates sagged, and the agency's answer was to raise budgets to compensate.

Prescription. Rebalance to 65/35. The extra production budget funded monthly micro-shoots — phone-shot, creator-led, lo-fi on purpose. Volume and variety over polish.

Prognosis. Creative refresh cycles went from quarterly to monthly. Cost per acquisition fell steadily as ad fatigue stopped taking hold. The yearly mega-shoot was retired entirely.

Patient Four: The Trade Business Chasing Followers

Presenting symptoms. A UK trades franchise paying a freelancer a monthly retainer explicitly tied to follower growth targets. Six months in: 9,000 followers, three enquiries.

Diagnosis. The wrong vital sign entirely. Follower count is the least diagnostic number on any report — it tells you nothing about whether the audience can buy, wants to buy, or even lives in your service area.

Prescription. Rip up the follower KPI. Replace it with enquiry volume, cost per enquiry, and response rate. Refocus content on the questions customers actually ask, in the postcodes actually served.

Prognosis. Followers plateaued. Enquiries tripled within a quarter. Nobody in the business misses the follower count.

Patient Five: The Spread-It-Everywhere Startup

Presenting symptoms. A consumer startup dividing a modest £2,000 monthly budget evenly across five platforms because "we want to be everywhere."

Diagnosis. Underdosing. £400 a platform isn't a strategy; it's a placebo. No channel received enough investment to generate learning, let alone results.

Prescription. Concentrate. Pick the two channels where their audience demonstrably spends time, put 85% of budget there, and treat the rest as dormant until the first two are performing.

Prognosis. Two channels, properly funded, produced the brand's first attributable revenue within ten weeks. The other three accounts stay open — but nobody's pretending they're a strategy.

The Common Condition

Five budgets, five different businesses, one underlying ailment: money allocated by habit or by fear rather than by diagnosis. Budgets aren't spreadsheets to be defended — they're treatment plans to be reviewed.

If any of these patients sounded uncomfortably familiar, that's not a coincidence. These are the five most common conditions we see, and all five responded well to treatment. The first appointment is always the same: an honest look at where the money's actually going, and whether it's connected to anything that matters.

Book your own health check before the next budget cycle. Your finance director will thank you.